Kevan Jones
Shadow Minister (Defence)
To ask the Secretary of State for Health, when NHS England will issue a commissioning position on the use of Lomitapide for the treatment of Homozygous Familial Hypercholesterolemia; and if he will make a statement.
George Freeman
The Parliamentary Under-Secretary of State for Business, Innovation and Skills, The Parliamentary Under-Secretary of State for Health
NHS England is reviewing a number of interventions that will be considered for commissioning from April 2016. Lomitapide for homozygous familial hypercholesterolemia is one of those interventions being considered.
Services for patients with homozygous familial hypercholesterolaemia have become NHS England’s direct commissioning responsibility since 1 April 2015.
Does this answer the above question?
Yes0 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.